Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients w

Date publication

juin 2026

Journal

European urology oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr QUIVRIN Magali

Tous les auteurs :
Josset Q, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Zhou K, Mesgouez-Nebout N, Supiot S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42276876

Résumé

The management of oligorecurrent pelvic lymph nodes in patients with prostate cancer is debated. Intermittent androgen-deprivation therapy (ADT; IADT) is often proposed. Elective pelvis irradiation (ENRT) may prolong tumor control and decrease subsequent spread.

Mots clés

Choline, Clinical trial, ENRT, Hormonal therapy, MDT, PSMA, Prostate cancer, Radiation therapy, SBRT

Référence

Eur Urol Oncol. 2026 06 11;: